BSPP (drug)
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
IUPAC name
| |
PubChem CID | |
ChemSpider | |
Chemical and physical data | |
Formula | C21H34O2 |
Molar mass | 318.501 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
BSPP is a compound used in scientific research which acts as a positive allosteric modulator at the GABAB receptor.[1] It has a synergistic effect with GABAB agonists such as baclofen at GABAB autoreceptors but not heteroreceptors, suggesting it may be useful for distinguishing between these GABAB receptor subtypes.[2]
References
- ↑ Kerr DI, Khalafy J, Ong J, Perkins MV, Prager RH, Puspawati NM, Rimaz M (September 2006). "Synthesis and biological activity of allosteric modulators of GABAB receptors, part 2. 3-(2, 6-bis-tert-butyl-4-hydroxyphenyl) propanols". Australian Journal of Chemistry. 59 (7): 457–62. doi:10.1071/CH06164.
- ↑ Parker DA, Marino V, Ong J, Puspawati NM, Prager RH (September 2008). "The CGP7930 analogue 2,6-di-tert-butyl-4-(3-hydroxy-2-spiropentylpropyl)-phenol (BSPP) potentiates baclofen action at GABA(B) autoreceptors". Clinical and Experimental Pharmacology & Physiology. 35 (9): 1113–5. doi:10.1111/j.1440-1681.2008.04948.x. PMID 18430050. S2CID 25608408.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.